$4.06
+0.18 (+4.64%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+463.8% upside
Low Target
$19.41
Average Target
$22.89
High Target
$38.59
Current Price
$4.06
Current
$4.06
$4.06
Target
$22.89
$22.89
$19.41
$22.89 avg
$38.59
Scenario Analysis
Bear Case
$19.41
378.1%
Low target
Base Case
$22.89
+463.8%
Avg target
Bull Case
$38.59
+850.5%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$11.88
-65.8% from high
52-Week Low
$2.14
+89.7% from low
Target vs 52W High
$22.89
+92.7% vs high
Next Earnings Report
Aug 19, 2026
3d
until earnings
EPS Est: $-0.50
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |